A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric ...

Ambroxol is commonly used as an expectorant in cough syrup, helping thin out mucus so people with respiratory illnesses can ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...

An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...

A common cough syrup, Ambroxol, has shown potential in slowing the progression of Parkinson's dementia in a recent clinical trial.

Ambroxol’s appeal lies in its ability to help cells produce more of a crucial enzyme called glucocerebrosidase (GCase). This enzyme, encoded by the GBA1 gene, helps cells break down waste.

A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for protecting the brain. In a year-long clinical trial, researchers gave Ambroxol to ...